About Abingdon Health
Abingdon Health is a company based in York (United Kingdom) founded in 2008.. Abingdon Health has raised $24.05 million across 8 funding rounds from investors including Mercia and Imperial Innovations. Abingdon Health has completed 2 acquisitions, including Compliance Solutions and Molecular Vision. Abingdon Health operates in a competitive market with competitors including Olink, US BioTek Laboratories, Spear Bio, Eclipse Bio and Virtue Diagnostics, among others.
- Headquarter York, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Abingdon Health Plc
-
Annual Revenue
$11.55 M (USD)37.39as on Jun 30, 2025
-
Net Profit
$-4.69 M (USD)-168.69as on Jun 30, 2025
-
EBITDA
$-4.69 M (USD)-137.46as on Jun 30, 2025
-
Total Equity Funding
$24.05 M (USD)
in 8 rounds
-
Latest Funding Round
$4.4 M (USD), Post-IPO
Oct 14, 2025
-
Investors
Mercia
& 1 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Compliance Solutions
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Abingdon Health
Abingdon Health is a publicly listed company on the LSE with ticker symbol ABDX in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Abingdon Health
Abingdon Health has successfully raised a total of $24.05M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $4.4 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $4.4M
-
First Round
First Round
(26 Mar 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Post-IPO - Abingdon Health | Valuation |
investors |
|
| Jan, 2019 | Amount | Series A - Abingdon Health | Valuation | Mercia |
|
| Dec, 2017 | Amount | Series A - Abingdon Health | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Abingdon Health
Abingdon Health has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Mercia and Imperial Innovations. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in startups are focused on Europe and the US.
|
Founded Year | Domain | Location | |
|
Investment management services are provided by Mercia to various clients.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Abingdon Health
Abingdon Health has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Compliance Solutions and Molecular Vision. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Consultancy firm providing regulatory advice and compliance services to life science companies, specializing in medical devices, IVD, and pharmaceuticals
|
2008 | ||||
|
Optical detection platforms for portable medical diagnostics are developed.
|
2001 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Abingdon Health
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Abingdon Health Comparisons
Competitors of Abingdon Health
Abingdon Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Olink, US BioTek Laboratories, Spear Bio, Eclipse Bio and Virtue Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of products and services for human protein biomarker research and development
|
|
| domain | founded_year | HQ Location |
Provider of enzyme-linked immunosorbent assay technology services
|
|
| domain | founded_year | HQ Location |
Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers
|
|
| domain | founded_year | HQ Location |
Cell-free immunoassays are developed to identify RNA binding protein targets.
|
|
| domain | founded_year | HQ Location |
An in vitro assay platform is provided for diagnostic solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Abingdon Health
Frequently Asked Questions about Abingdon Health
When was Abingdon Health founded?
Abingdon Health was founded in 2008 and raised its 1st funding round 4 years after it was founded.
Where is Abingdon Health located?
Abingdon Health is headquartered in York, United Kingdom.
Is Abingdon Health a funded company?
Abingdon Health is a funded company, having raised a total of $24.05M across 8 funding rounds to date. The company's 1st funding round was a Series A of $1.5M, raised on Mar 26, 2012.
What is the annual revenue of Abingdon Health?
Annual revenue of Abingdon Health is $11.55M as on Jun 30, 2025.
What does Abingdon Health do?
Abingdon Health was founded in 2008 in York, United Kingdom, within the diagnostics sector. Rapid lateral flow immunoassay systems enabling multiplexed immunodiagnostics are developed by the company. The flagship product, Seralite-FLC, measures kappa and lambda immunoglobulin-free light chains to detect hematological cancers. Research services are offered across clinical point-of-care, self-testing, pharmaceutical, and related sectors.
Who are the top competitors of Abingdon Health?
Abingdon Health's top competitors include Precipio Diagnostics, Eclipse Bio and Spear Bio.
Is Abingdon Health publicly traded?
Yes, Abingdon Health is publicly traded on LSE under the ticker symbol ABDX.
How many acquisitions has Abingdon Health made?
Abingdon Health has made 2 acquisitions, including Compliance Solutions, and Molecular Vision.
Who are Abingdon Health's investors?
Abingdon Health has 2 investors. Key investors include Mercia, and Imperial Innovations.
What is Abingdon Health's ticker symbol?
The ticker symbol of Abingdon Health is ABDX on LSE.